225 related articles for article (PubMed ID: 31797632)
1. PGxMine: Text mining for curation of PharmGKB.
Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
[TBL] [Abstract][Full Text] [Related]
2. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
Gong L; Whirl-Carrillo M; Klein TE
Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
[TBL] [Abstract][Full Text] [Related]
3. A mutation-centric approach to identifying pharmacogenomic relations in text.
Rance B; Doughty E; Demner-Fushman D; Kann MG; Bodenreider O
J Biomed Inform; 2012 Oct; 45(5):835-41. PubMed ID: 22683993
[TBL] [Abstract][Full Text] [Related]
4. Towards pathway curation through literature mining--a case study using PharmGKB.
Ravikumar KE; Wagholikar KB; Liu H
Pac Symp Biocomput; 2014; ():352-63. PubMed ID: 24297561
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
6. Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.
Pakhomov S; McInnes BT; Lamba J; Liu Y; Melton GB; Ghodke Y; Bhise N; Lamba V; Birnbaum AK
J Biomed Inform; 2012 Oct; 45(5):862-9. PubMed ID: 22564551
[TBL] [Abstract][Full Text] [Related]
7. Relation mining experiments in the pharmacogenomics domain.
Rinaldi F; Schneider G; Clematide S
J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
[TBL] [Abstract][Full Text] [Related]
8. Overview of the BioCreative VI Precision Medicine Track: mining protein interactions and mutations for precision medicine.
Islamaj Dogan R; Kim S; Chatr-Aryamontri A; Wei CH; Comeau DC; Antunes R; Matos S; Chen Q; Elangovan A; Panyam NC; Verspoor K; Liu H; Wang Y; Liu Z; Altinel B; Hüsünbeyi ZM; Özgür A; Fergadis A; Wang CK; Dai HJ; Tran T; Kavuluru R; Luo L; Steppi A; Zhang J; Qu J; Lu Z
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30689846
[TBL] [Abstract][Full Text] [Related]
9. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
[TBL] [Abstract][Full Text] [Related]
10. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
11. tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine.
Wei CH; Phan L; Feltz J; Maiti R; Hefferon T; Lu Z
Bioinformatics; 2018 Jan; 34(1):80-87. PubMed ID: 28968638
[TBL] [Abstract][Full Text] [Related]
12. PharmGKB: A worldwide resource for pharmacogenomic information.
Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
[TBL] [Abstract][Full Text] [Related]
13. A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions.
Hakenberg J; Voronov D; Nguyên VH; Liang S; Anwar S; Lumpkin B; Leaman R; Tari L; Baral C
J Biomed Inform; 2012 Oct; 45(5):842-50. PubMed ID: 22564364
[TBL] [Abstract][Full Text] [Related]
14. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
[TBL] [Abstract][Full Text] [Related]
15. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
Hernandez-Boussard T; Whirl-Carrillo M; Hebert JM; Gong L; Owen R; Gong M; Gor W; Liu F; Truong C; Whaley R; Woon M; Zhou T; Altman RB; Klein TE
Nucleic Acids Res; 2008 Jan; 36(Database issue):D913-8. PubMed ID: 18032438
[TBL] [Abstract][Full Text] [Related]
16. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
[TBL] [Abstract][Full Text] [Related]
17. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Hodge AE; Altman RB; Klein TE
Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
[TBL] [Abstract][Full Text] [Related]
18. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
19. Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.
Lever J; Jones MR; Danos AM; Krysiak K; Bonakdar M; Grewal JK; Culibrk L; Griffith OL; Griffith M; Jones SJM
Genome Med; 2019 Dec; 11(1):78. PubMed ID: 31796060
[TBL] [Abstract][Full Text] [Related]
20. PharmGKB: the Pharmacogenomics Knowledge Base.
Thorn CF; Klein TE; Altman RB
Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
